Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

NICE seeks more trial data from pharma

September 10, 2014
Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency

NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …

News
Celgene image

Celgene rebuffed by NICE over cancer drug

September 9, 2014
Sales and Marketing Abraxane, Cancer, Celgene, Gemzar, NICE, gemcitabine, nab-paclitaxel

In new draft guidance NICE says that Celgene’s Abraxane (nab-paclitaxel) taken with Lilly’s Gemzar (gemcitabine) should not be funded by …

News
Solaris image

NICE backs world’s most expensive medicine

September 4, 2014
Sales and Marketing AGNSS, Alexion, England, NICE, aHUS, solaris

In a U-turn on its previous guidance NICE is now recommending that the £330,000 rare disease drug Soliris should be …

News
Haslam image

NICE: Cancer Drugs Fund must use our processes

September 3, 2014
Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche

NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …

News

NICE and market access: time for reform?

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bristol-Myers Squibb, NICE, Yervoy, reform

Earlier in the year, at the ABPI’s annual conference, the UK pharma lobby group released a new report suggesting that …

Feature
Zytiga image

Charities ‘disappointed’ in NICE and Janssen

August 15, 2014
Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, prostate

The Institute of Cancer Research and Prostate Cancer UK are both urging NICE and Janssen to ‘get their act together’ …

News
Kadcyla packshot

Storm brewing over Roche cancer drug price

August 8, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Haslam, Kadcyla, NICE, Roche, Yervoy, rejection

The Breakthrough Breast Cancer charity and England’s drug pricing watchdog NICE have both attacked Roche for not lowering the price …

News
abpi_reception

ABPI president: NICE needs political reform

August 1, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, NICE, Pfizer, jonathan emms, vba

Jonathan Emms, the new president of the ABPI, is a man not shy about defending the rights of the UK …

Feature
celgene_1_02_1

NICE won’t back Revlimid in new setting

July 31, 2014
Medical Communications, Sales and Marketing Celgene, NICE, Revlimid, Thalidomide, multiple myeloma

NICE has once again said it does not think that Celgene’s rare cancer drug Revlimid should be used on the …

News
sovaldi_ariad_sofosbuvir_bottle_1

NHS England’s Sovaldi fund: opening the floodgates?

July 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDG, NICE, Professor David Haslam, hep C, sovaldi

Whilst seemingly more and more barriers are being erected to slow down the adoption of new medicines, there is a …

Feature
Lilly image

NICE extends recommendation for Efient

July 24, 2014
Sales and Marketing ACS, Efient, NICE, Plavix, longs ton, prasugrel

In updated guidance NICE has extended its recommendation of Efient (prasugrel) in combination with aspirin for preventing blood clots in …

News
Yervoy image

NICE ‘yes’ for cancer drugs

July 23, 2014
Sales and Marketing Astellas, BMS, Cancer, NICE, Xtandi, Yervoy

Two big-name oncology brands, Bristol-Myers Squibb’s Yervoy and Astellas Pharma’s Xtandi, have been given the nod by drug costs watchdog …

News
selincro image

NICE ‘yes’ for Selincro

July 10, 2014
Sales and Marketing Lundbeck, NHS, NICE, alcohol, nalmefene, selincro

Lundbeck has received a lift from UK drugs pricing watchdog NICE as it has recommended the firm’s alcohol dependency pill …

News
jonathan_emms_close

ABPI president: NICE needs political reform

June 17, 2014
Business Services, Medical Communications, Research and Development ABPI, NHS, NICE, Pfizer, QALY, emms, jonathan, vba

NICE needs to be reformed with its QALY formula heavily revised if it is to meet the challenges of 21st …

News
gilead_-sciences

NICE rejection looms for Sovaldi

June 16, 2014
Sales and Marketing Gilead, NHS, NICE, SMC, hep C, sofosbuvir, sovaldi

In a draft recommendation published today NICE is asking Gilead for more information on its new hepatitis C pill Sovaldi …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026